Life Sciences Pulse

Global Ventures

Our Global Ventures strategy seeks to partner with entrepreneurs building transformational early-stage technology businesses.

Our global investment platform aims to create significant differentiation in the venture space

Venture capital investors differentiate themselves based on their access, selectivity, and ability to add value. We believe our experience and synergies across our both public and private platforms at Sands Capital gives us an advantage.

Our Investment Focus

Geography

Emerging Tech Hubs

Stage

Series A & B Focused

Pie Chart

Concentration

$10M – $15M
total investment size
per company

We invest in data- driven disruption

Data proliferation and rapid digitalization are redefining the world and creating generational opportunities. We aim to partner with entrepreneurs leveraging this disruption to build the next market leaders within their industries. As the earliest stage investment strategy at Sands Capital, we are long-term partners for growth, who support our portfolio companies through our combination of deep domain expertise and operating experience.

AI / ML will become a critical technology embedded within software, enabling transformative new applications, but also requiring a new suite of developer tools and data infrastructure.

Our online identity defines how we work and access critical applications and services – these online identities must be secured, and their data protected.

Healthcare institutions must adopt new technologies to improve the patient experience, automate manual processes, and enable a higher quality of care.

Consumers are increasingly working, playing, socializing, and transacting online, creating opportunities for businesses to shape these experiences through digital worlds and virtual goods.

Partners for Long-term Growth

Our experienced team is dedicated to cultivating deep, enduring partnerships with entrepreneurs and helping them grow their businesses.

Acessa colorful black logo title
Status: Exited
Category: Life Sciences
Partner Since: June 2017
Acessa Health
1496277217
Acessa colorful black logo title

Show details

Acumen pharmaceuticals logo title
Status: NASDAQ: ABOS
Category: Life Sciences
Partner Since: November 2020
Acumen Pharmaceuticals
1604245740
Acumen pharmaceuticals logo title

Show details

Agilis logo
Status: Exited
Category: Life Sciences
Partner Since: February 2017
Agilis Bio
1485964200
Agilis logo

Show details

Avitide logo title color colors
Status: Exited
Category: Life Sciences
Partner Since: June 2017
Avitide
1496282520
Avitide logo title color colors

Show details

Big basket logo title green red black
Status: Exited
Category: Technology
Partner Since: October 2015
BigBasket
1443664920
Big basket logo title green red black

Show details

Blackbuck red title logo
Status: Active
Category: Technology
Partner Since: January 2017
BlackBuck
1483232460
Blackbuck red title logo

Show details

boom logo
Status: Active
Category: Technology
Partner Since: July 2019
Boom Entertainment
1561982520
boom logo

Show details

Brightflag logo title
Status: Active
Category: Technology
Partner Since: March 2019
Brightflag
1551402060
Brightflag logo title

Show details

Candel therapeutics logo
Status: Active
Category: Life Sciences
Partner Since: March 2019
Candel
1551402060
Candel therapeutics logo

Show details

Coagulo medical technologies red title logo
Status: Active
Category: Life Sciences
Partner Since: April 2019
Coagulo
1554080460
Coagulo medical technologies red title logo

Show details

Status: Active
Category: Technology
Partner Since: December 2021
Codoxo
1638320460

Show details

Status: Active
Category: Technology
Partner Since: March 2022
Credo.ai
1646096460

Show details

datarobot logo title black blue
Status: Active
Category: Technology
Partner Since: July 2019
DataRobot
1561942860
datarobot logo title black blue

Show details

Day zero diagnostics orange gray title logo
Status: Active
Category: Life Sciences
Partner Since: August 2017
Day Zero
1501549260
Day zero diagnostics orange gray title logo

Show details

Status: NASDAQ: DICE
Category: Life Sciences
Partner Since: July 2018
DiCE Molecules
1530406860

Show details

Farcast bioscinces title logo purple black
Status: Exited
Category: Life Sciences
Partner Since: August 2016
Farcast Bio
1470013260
Farcast bioscinces title logo purple black

Show details

freenome title logo black
Status: Active
Category: Life Sciences
Partner Since: July 2019
Freenome
1561942860
freenome title logo black

Show details

#paid logo
Status: Active
Category: Technology
Partner Since: July 2019
#paid
1561995720
#paid logo

Show details

Status: Active
Category: Technology
Partner Since: December 2022
Hawk:AI
1669856460

Show details

Hungry logo
Status: Active
Category: Technology
Partner Since: February 2019
Hungry
1548982860
Hungry logo

Show details

indigo black logo
Status: Active
Category: Technology
Partner Since: March 2017
Indigo Technologies
1488330060
indigo black logo

Show details

Load More

A Bold Mission Requires a Strong Team

With decades of experience as pure growth investors, we know what it took for today’s leading businesses to get to the top, and together we can help the next generation of entrepreneurs get there.

Three man talking
a man in a suit looking into the camera

Scott Frederick

Managing Partner

a man with gray hair wearing dark-rimmed glasses wearing a white shirt and a black striped suit smiles at the camera

Michael Graninger

Managing Partner

Headshot Mark McGovern

Mark McGovern

Venture Partner

a man in black hair wearing a jacket and a blue and white checkered shirt smiles at the camera

Christopher Eng

Principal

red-haired man in a jacket smiles at the camera

Nick Graziano, CFA

Principal, Portfolio Services

a woman in a red shirt and jacket smiles at the camera

Christy Steele

Principal

Andrew Giordano

Andrew P. Giordano

Managing Director, Business Development and Client Relations

Scott Headd

Scott Headd

Sr. Director, Client Relations

a man in a blue checkered shirt with a checkered jacket smiles at the camera

Stephen F. Nimmo

Executive Managing Director, Business Development and Client Relations

a woman in a black blouse looking at the camera

Miriam Z. Sanders

Director, Investor Relations

Alexandra Fulk

Alexandra Fulk

Chief Compliance Officer, Sr. Counsel

a man with gray hair in a black jacket and a white shirt smiles at the camera

Jonathan P. Goodman

General Counsel

a woman with brown hair and brown eyes wearing a necklace in a black blouse smiles at the camera

Yolande J. Hanlan

Director, Sr. Counsel

Morgan Lee

Morgan Lee

Legal Counsel

a woman with fair hair wearing a gray stone butcher wearing a burgundy blouse smiles at the camera

Erin Soule, CPA

Managing Director, Head of Private Markets Finance and Operations

Related Thinking

Business Perspectives
Bringing Governance to AI
Navrina Singh and Credo AI are helping organizations build AI responsibly, by providing an AI governance software platform to ensure technology is fair, compliant, safe, secure, auditable, and human centered.
Investment Strategy
Enabling the Data-driven Enterprise
While there is a long road ahead before data-driven decision-making becomes common across organizations, we believe businesses that enable this data stack will be an important area for venture capital investment in the years to come.
Business Perspectives
Innovative Game Play That Is Proven, Better, and New
Boom Entertainment and its CEO, Stephen Murphy, are making sports gaming accessible—and fun—to a broader market of consumers.
Investment Strategy
Powering Everything
ChatGPT has practically turned chipmaker NVIDIA into a household name. We believe NVIDIA and other companies along the semiconductor value chain should grow more than expected, benefitting not only from AI adoption but also from other new technologies that demand more powerful and more complex chips.

The Global Ventures strategy is concentrated in a limited number of emerging technology companies. Some of the risks impacting the strategy include cybersecurity risk, cryptocurrency risk, risks associated with investing in India and China and special risks, such as products or services not proving commercially successful or quickly becoming obsolete.

Investment in a fund involves significant risk. No assurance can be given that a fund’s investment objectives will be achieved. An investment is only suitable for sophisticated investors for whom an investment does not constitute a complete investment program, who have experience with similar types of investments, and who understand, are willing to assume, and have the financial resources necessary to withstand the significant risks involved in the investment, including the potential for a complete loss of capital. Please review the risks outlined in the Private Placement Memorandum prior to investing.

The logos and website images used are used for illustrative purposes only and were obtained directly from the relevant companies’ websites. The logo and website images are trademarks or registered trademarks of the companies and their use in this presentation does not imply any connection between us and the companies.

As of October 1, 2021, Sands Capital was redefined to be the combination of Sands Capital Management, LLC and Sands Capital Ventures. Both firms are registered investment advisers with the United States Securities and Exchange Commission in accordance with the Investment Advisers Act of 1940. The two registered investment advisers are combined to be one firm and are doing business as Sands Capital. Sands Capital operates as a distinct business organization, retains discretion over the assets between the two registered investment advisers, and has autonomy over the total investment decision-making process.